Blood Test News and Research

RSS

Scientists discover 36 previously unknown genes implicated in heart failure

One in four deaths in the United States each year are due to heart disease, according to the Centers for Disease Control and Prevention. It's the leading killer of both men and women, but the disease's genetic complexity makes it difficult to treat.

8 Mar 2018

Research identifies new biomarkers for future dementia risk

Sudha Seshadri, M.D., founding director of the Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases at UT Health San Antonio, is co-leader and senior author on research announced March 6 that identifies novel biomarkers of risk for future dementia.

6 Mar 2018

One-month antibiotic regimen to prevent TB as safe, effective as nine-month therapy for HIV patients

A one-month antibiotic regimen to prevent active tuberculosis (TB) disease was at least as safe and effective as the standard nine-month therapy for people living with HIV, according to the results of a large international clinical trial.

6 Mar 2018

Infants process pain in their brains in different ways based on age

Reliance on behavioral indicators, such as crying, to assess pain in infants underestimates how much pain babies actually feel when they undergo stressful medical procedures.

5 Mar 2018

IQuity launches pioneering RNA-based blood test to diagnose fibromyalgia

Nashville-based data science company IQuity has announced the release of IsolateFibromyalgia™, a pioneering blood test that uses RNA analysis to help health care providers accurately and quickly detect fibromyalgia syndrome.

5 Mar 2018

Machine learning can help accurately predict clinical outcomes in patients with heart problems

Several studies being presented at the American College of Cardiology's 67th Annual Scientific Session demonstrate how the computer science technique known as machine learning can be used to accurately predict clinical outcomes in patients with known or potential heart problems.

1 Mar 2018

Volition declares interim results from first asymptomatic CRC frontline screening study

VolitionRx Limited today announced interim results from its first asymptomatic colorectal cancer frontline screening study. This ongoing study is being carried out in collaboration with Hvidovre Hospital, University of Copenhagen, Denmark and involves 680 subjects from the Danish National CRC Screening Program.

28 Feb 2018

BGN Technologies collaborates with Biosensorix to develop new cost-effective diagnostic kit

BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev, announced today its collaboration with Biosensorix, a Singapore-based company in the field of medical diagnostics, to develop next-generation, quantitative, point-of-care diagnostics based on research conducted at Ben-Gurion University.

27 Feb 2018

AMSSM explains why FDA-approved blood test is not about concussion

On February 14th, the U.S. Food and Drug Administration approved a blood test that has been proposed to diagnose concussion.

24 Feb 2018

New study identifies novel molecular biomarkers of preeclampsia

Preeclampsia, a sudden pregnancy complication that can interfere with the blood flow to the placenta and possibly to the fetus, can lead to low birth weight, prematurity and even death.

22 Feb 2018

University Hospital of Santiago de Compostela participates in large pancreatic cancer study

International validation through collaboration with leading cancer centers in Europe and US is a key part of Immunovia’s development and commercialization strategy for its portfolio of IMMray tests.

19 Feb 2018

New blood test shows promise to revolutionize diagnosis of tick-borne diseases

A new blood test called the Tick-Borne Disease Serochip (TBD Serochip) promises to revolutionize the diagnosis of tick-borne disease by offering a single test to identify and distinguish between Borrelia burgdorferi, the pathogen responsible for Lyme disease, and seven other tick-borne pathogens.

18 Feb 2018

FDA permits marketing of first blood test to evaluate mild traumatic brain injury

The U.S. Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to as concussion, in adults.

15 Feb 2018

Testing for alpha fetoprotein may improve early liver cancer detection, finds study

A new study found that ultrasound imaging in combination with a blood test for alpha fetoprotein improved the detection of early-stage liver cancer by 40%.

12 Feb 2018

Combining ultrasound with blood test improves detection of liver cancer by 40%

Combining ultrasound imaging with a blood test for high alpha fetoprotein levels improves detection of early-stage liver cancer by as much as 40 percent, researchers at UT Southwestern's Simmons Cancer Center found.

11 Feb 2018

Massachusetts General Hospital to participate in PanFAM-1 hereditary pancreatic cancer risk study

Immunovia AB today announced that Massachusetts General Hospital is to participate in PanFAM-1, a multicenter prospective validation study for the early diagnosis in high-risk individuals with Familial Pancreatic Cancer.

9 Feb 2018

New blood test offers quick, accurate diagnosis of deadly yeast infection

A new blood test seems to perform as well as, if not better than, traditional blood cultures at detecting a type of fungal yeast infection that commonly strikes hospital patients, according to an analysis led by UPMC.

8 Feb 2018

New blood test could provide clues as to why some patients are at higher risk after heart attack

A new study from the University of Sheffield has shown a new blood test could provide a clue as to why some patients are at higher risk of cardiovascular disease risk after suffering a heart attack.